Vontobel Holding Ltd. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 20,420 shares of the company’s stock, valued at approximately $2,705,000.
A number of other institutional investors have also made changes to their positions in the business. Legato Capital Management LLC raised its holdings in shares of Astera Labs by 68.2% in the fourth quarter. Legato Capital Management LLC now owns 25,612 shares of the company’s stock valued at $3,392,000 after buying an additional 10,386 shares during the last quarter. Peterson Wealth Services acquired a new stake in Astera Labs in the fourth quarter worth about $1,208,000. Essex Financial Services Inc. increased its position in Astera Labs by 1.9% in the fourth quarter. Essex Financial Services Inc. now owns 24,939 shares of the company’s stock worth $3,303,000 after purchasing an additional 468 shares during the period. Comprehensive Financial Planning Inc. PA acquired a new stake in Astera Labs in the fourth quarter worth about $250,000. Finally, Entropy Technologies LP acquired a new stake in Astera Labs in the fourth quarter worth about $1,742,000. 60.47% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
ALAB has been the subject of a number of research reports. Citigroup initiated coverage on Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective for the company. Roth Mkm lifted their price objective on Astera Labs from $80.00 to $105.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. Barclays lifted their price objective on Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research report on Friday, January 17th. Stifel Nicolaus lifted their price objective on Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 5th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $115.33.
Astera Labs Trading Down 0.4 %
NASDAQ:ALAB opened at $87.85 on Monday. Astera Labs, Inc. has a fifty-two week low of $36.22 and a fifty-two week high of $147.39. The business’s 50-day simple moving average is $120.17 and its 200-day simple moving average is $83.51.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current year.
Insider Activity
In other Astera Labs news, Director Stefan A. Dyckerhoff sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $105.90, for a total value of $3,177,000.00. Following the sale, the director now owns 3,765 shares in the company, valued at approximately $398,713.50. The trade was a 88.85 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Manuel Alba sold 11,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the completion of the sale, the director now owns 456,863 shares in the company, valued at $53,681,402.50. The trade was a 2.35 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 639,244 shares of company stock worth $67,669,886 in the last 90 days.
Astera Labs Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Stories
- Five stocks we like better than Astera Labs
- Do ETFs Pay Dividends? What You Need to Know
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- With Risk Tolerance, One Size Does Not Fit All
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.